Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study

J Neurol. 2019 Dec;266(12):3047. doi: 10.1007/s00415-019-09549-w.

INTEREST IN CD2 study group:
A Abdulnayef, N U Adatepe, M A Araujo Leite, S Badarny, O Bajenaru, M Bares, P Bejjani, B Bergmans, R Bhidayasiri, H Bozic, F E Cardoso Costa, C Carlstrom, G Castelnovo, M H Chang, Y Y Chang, T M Chung, M Coletti-Moja, V Delvaux, P Dioszhegy, O Dogu, W Duzynski, E Ehler, L Espinosa Sierra, G Fabbrini, J Ferreira, A Ferreira Valadas, C Foresti, P Girlanda, K J Goh, A Graca Velon, S Grill, T Gurevitch, M Hadidi, M A Hamimed, A Hamri, T Harrower, S Hassin, P Hedera, J F J G Hernandez, J Hernandez Franco, B Ho, S L Ho, A Hughes, T Ilic, J S Inshasi, C W Ip, S Jamieson, R D G Jamora, R Jech, B S Jeon, A Kaminska, M Karpova, D Khasanova, J M Kim, J W Kim, C Y Kok, A Korenko, J Korv, S Koussa, T Kovacs, A Kreisler, P Krystkowiak, W Kumthornthip, C H Lin, F Lundin, G Lus, M Magalhaes, A N Masmoudi, R Mercelis, A Misbahuddin, C Moebius, B Mohammadi, B Nazem, K Ng, G Nurlu, J Nyberg, D Nyholm, S Ochudlo, P Otruba, R Pfister, Z Pirtosek, D Pokhabov, S Quinones Aguilar, G Quinones Canales, S Raghev, H Rickmann, M Romano, R L Rosales, I Rubanovits, V Santilli, L Schoels, M Simonetta-Moreau, M A Simu, Y H Sohn, S Soulayrol, I Supe, M Svetel, T Sycha, E K Tan, S Timerbaeva, A B Tokcaer, R Trosch, V Tugnoli, V Tumas, C Van der Linden, A Vetra, C Vial, E Vidry, D Williams, S Wimalaratna, C Yiannikas

¹ Department of Neurology, Santa Maria University Hospital, Viale Tristano di Joannuccio 1, 05100, Terni, Italy. carlo.colosimo@uniroma1.it.
² Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
³ Department of Neurology, Imperial College Healthcare NHS Trust, London, UK.
⁴ Ipsen Pharma, Boulogne-Billancourt, France.

Abstract

The article How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment?